Perioperative Tranexamic Acid Should Be Considered for Total Joint Arthroplasty Patients Receiving Apixaban for Thromboprophylaxis

Perioperative Tranexamic Acid Should Be Considered for Total Joint Arthroplasty Patients Receiving Apixaban for Thromboprophylaxis

Background: This study aims to investigate if the perioperative administration of tranexamic acid (TXA) for total joint arthroplasty (TJA) patients receiving apixaban for thromboprophylaxis can reduce the risk of postoperative bleeding without increasing the rate of thromboembolic events. Methods: T...

Full description

Saved in:
Bibliographic Details
Main Authors: Sagar Telang, BS, Ryan Palmer, BS, Andrew Dobitsch, MD, Jacob R. Ball, MD, Nathanael D. Heckmann, MD, Jay R. Lieberman, MD
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Arthroplasty Today
Subjects:
Total joint arthroplasty
Tranexamic acid
Apixaban
Transfusion
Deep vein thrombosis
Pulmonary embolism
Online Access:http://www.sciencedirect.com/science/article/pii/S2352344124002334
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items